Extract

The first study with rivaroxaban in pediatric subjects is a Phase I study, where the pharmacokinetic/pharmacodynamic (PK/PD) profile of rivaroxaban will be investigated to confirm that the exposure is comparable to adults. This study is a single dose study with multiple PK/PD measurements in pediatric subjects at the end of their Venous Thromboembolism (VTE) treatment.

Inclusion criteria

• Venous Thrombosis ,Pediatrics

Country

• Australia
• Austria
• Canada
• France
• Germany
• Ireland
• Israel
• Italy
• Switzerland
• United States

Links

• ictrp
• nct